{"id":"mosapride-citrate-tablets","safety":{"commonSideEffects":[{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Abdominal pain"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Mosapride selectively binds to and activates 5-HT4 (serotonin-4) receptors in the gastrointestinal tract, which increases acetylcholine release and enhances smooth muscle contractions in the stomach. This promotes more efficient gastric emptying and improves overall gastric motility, helping to relieve symptoms associated with functional dyspepsia and gastroesophageal reflux.","oneSentence":"Mosapride citrate is a 5-HT4 receptor agonist that enhances gastric motility and accelerates gastric emptying.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:22:08.177Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Functional dyspepsia"},{"name":"Gastroesophageal reflux disease (GERD)"},{"name":"Postoperative ileus"}]},"trialDetails":[{"nctId":"NCT07182890","phase":"PHASE4","title":"Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia","status":"RECRUITING","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2025-09-20","conditions":"Functional Dyspepsia, Probiotics, Depression","enrollment":180},{"nctId":"NCT07187492","phase":"PHASE4","title":"Efficacy of Bacillus Coagulans in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia","status":"RECRUITING","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2025-09-20","conditions":"Functional Dyspepsia, Probiotics, Depression","enrollment":180},{"nctId":"NCT06826443","phase":"PHASE3","title":"A Comparative Evaluation of Mosapride Versus Metoclopramide for Enteral Feeding Intolerance in Critically Ill Patients","status":"NOT_YET_RECRUITING","sponsor":"Ain Shams University","startDate":"2025-02","conditions":"Enteral Feeding Intolerance","enrollment":100},{"nctId":"NCT06481371","phase":"NA","title":"Zuojin Wan Combined With Rabeprazole or Mosapride for the Treatment of Functional Dyspepsia Combined With Depression","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2024-06-30","conditions":"Functional Dyspepsia, Depression","enrollment":120},{"nctId":"NCT06156995","phase":"NA","title":"Deep Needling at Zhongliao Point to Stimulate the Sacral Nerve for the Treatment of Slow Transit Constipation","status":"UNKNOWN","sponsor":"Guoliang Wu","startDate":"2023-01-01","conditions":"Constipation","enrollment":70},{"nctId":"NCT05720442","phase":"PHASE1, PHASE2","title":"Efficacy Assessment of Chinese Herbal Medicine Tangweian Recipe Treating Participants With Diabetic Gastroenteropathy","status":"UNKNOWN","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2023-02-01","conditions":"Diabetic Gastroenteropathy","enrollment":60},{"nctId":"NCT04350346","phase":"NA","title":"The Comparative Analysis Between Motilitone and Gasmotin for the Symptom Relief in Gallstone Patients With Functional Dyspepsia","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2020-03-25","conditions":"Gallstone","enrollment":70},{"nctId":"NCT03149393","phase":"PHASE1, PHASE2","title":"Clinical Study on Post Evaluation After Listing of Qizhi Weitong Granules","status":"UNKNOWN","sponsor":"Xiyuan Hospital of China Academy of Chinese Medical Sciences","startDate":"2017-02-01","conditions":"Functional Dyspepsia, Traditional Chinese Medicine","enrollment":384},{"nctId":"NCT03477266","phase":"PHASE3","title":"Mouth Dissolving Mosapride Tables Enhance Post Cesarean Gut Recovery","status":"COMPLETED","sponsor":"Benha University","startDate":"2018-04-01","conditions":"Prevention of Postoperative Ileus","enrollment":400},{"nctId":"NCT02180334","phase":"PHASE4","title":"The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2014-07","conditions":"Diabetes Mellitus, Type 2","enrollment":12},{"nctId":"NCT03040817","phase":"NA","title":"Cooperative Group for Clinical Research in G-POEM (POP), Jiangsu, China","status":"UNKNOWN","sponsor":"Zhongda Hospital","startDate":"2017-09-01","conditions":"Gastric Peroral Endoscopic Pyloromyotomy (G-POEM)","enrollment":50},{"nctId":"NCT02201316","phase":"PHASE1","title":"A Pilot Study to Determine the Relative Bioavailability of Mosapride 5mg From Two Candidate Formulations of GR107719B Relative to One 5mg Tablet of Reference Mosapride Citrate (GASMOTIN™) in Healthy Adult Human Subjects Under Fasting Conditions","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-02-03","conditions":"Gastritis","enrollment":18},{"nctId":"NCT02984930","phase":"NA","title":"Effect of Proton Pump Inhibitor and Mosapride on Acid Pocket in Gastroesophageal Reflux Disease","status":"UNKNOWN","sponsor":"Gangnam Severance Hospital","startDate":"2016-12","conditions":"Gastroesophageal Reflux Disease","enrollment":30},{"nctId":"NCT01274793","phase":"PHASE1","title":"Trial for Quantity-Effect Relationship of Acupuncture With Two-ways Regulation to Treat Functional Enteropathy","status":"UNKNOWN","sponsor":"Huazhong University of Science and Technology","startDate":"2010-11","conditions":"Functional Constipation, Functional Diarrhea","enrollment":240},{"nctId":"NCT01781897","phase":"PHASE1","title":"Electroacupuncture for the Treatment of Functional Constipation","status":"UNKNOWN","sponsor":"Huazhong University of Science and Technology","startDate":"2013-02","conditions":"Functional Constipation","enrollment":243},{"nctId":"NCT00742872","phase":"PHASE3","title":"Randomized Trial of Mosapride Versus Placebo in the Treatment of Constipation-Predominant Irritable Bowel Syndrome","status":"TERMINATED","sponsor":"American University of Beirut Medical Center","startDate":"2008-09","conditions":"Constipation-Predominant Irritable Bowel Syndrome","enrollment":41},{"nctId":"NCT01094847","phase":"PHASE1","title":"Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride Medicine","status":"COMPLETED","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2010-04","conditions":"Bioequivalence","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["The Control Group"],"phase":"phase_3","status":"active","brandName":"Mosapride Citrate Tablets","genericName":"Mosapride Citrate Tablets","companyName":"Xiyuan Hospital of China Academy of Chinese Medical Sciences","companyId":"xiyuan-hospital-of-china-academy-of-chinese-medical-sciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Mosapride citrate is a 5-HT4 receptor agonist that enhances gastric motility and accelerates gastric emptying. Used for Functional dyspepsia, Gastroesophageal reflux disease (GERD), Postoperative ileus.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}